Intellectual Property Rights and the Evergreening of Pharmaceuticals
Ralf Boscheck ()
Intereconomics: Review of European Economic Policy, 2015, vol. 50, issue 4, 221-226
Abstract:
Escalating he althcare expenditures and the need to ensure access to affordable medicine in both emerging and emerged economies are fuelling calls to contain the so-called evergreening practices of drug producers around the world. But such practices are the necessary outcome of a system that responds to market incentives and appears to be already sufficiently controlled by established patentability standards and policies that determine patent term extension. The key issues surrounding current trade disputes lie deeper. This article examines the link between technological advances and intellectual property rights in general and the presumably special case of drug supplies. It focuses on strategies for extending the market exclusivity for pharmaceuticals products and evaluates safeguards against such evergreening. Copyright ZBW and Springer-Verlag Berlin Heidelberg 2015
Date: 2015
References: Add references at CitEc
Citations:
Downloads: (external link)
http://hdl.handle.net/10.1007/s10272-015-0546-y (text/html)
Access to full text is restricted to subscribers.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:intere:v:50:y:2015:i:4:p:221-226
Ordering information: This journal article can be ordered from
http://link.springer.de/orders.htm
DOI: 10.1007/s10272-015-0546-y
Access Statistics for this article
Intereconomics: Review of European Economic Policy is currently edited by Christian Breuer
More articles in Intereconomics: Review of European Economic Policy from Springer, ZBW - Leibniz Information Centre for Economics, Centre for European Policy Studies (CEPS)
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().